Maternal illness and its impact on fetal brain development through epigenetics: A closer look at the science behind neurodevelopmental disorders
The link between maternal illness and neurodevelopmental disorders has long been a subject of scientific inquiry, and recent research from the Salk Institute has shed new light on this complex relationship. The study, published in Molecular Psychiatry, reveals how severe illness during pregnancy can reshape fetal brain development through epigenetic modifications, offering valuable insights into the underlying causes of neurodevelopmental conditions.
The Epigenetic Connection
The Salk Institute researchers focused on the epigenomes of mouse frontal cortex cells, which are all the chemical tags and modifications on top of the base genetic code. By comparing the epigenomes of mouse offspring from healthy mothers and those from immune-activated mothers, they uncovered thousands of epigenetic differences. These differences were particularly pronounced in deep-layer neurons, with many of them located near genes associated with autism spectrum disorders.
This discovery highlights the potential for epigenetic changes to influence neurodevelopment, creating lasting alterations in brain circuitry that persist into adulthood. The study's findings suggest that maternal immune activation can lead to epigenetic modifications that disrupt the normal development of deep-layer neurons, which are crucial for various cognitive functions.
A Historical Perspective
The connection between maternal illness and neurodevelopmental disorders dates back decades. Scientists initially observed that mothers who contracted influenza during the second or third trimesters of pregnancy were more likely to have offspring with psychiatric disorders. This phenomenon sparked further investigation, leading to the discovery of elevated IL-6 levels in the maternal bloodstream, a protein associated with inflammation.
By creating rodent models that mimicked the immune response to influenza, researchers were able to establish a link between maternal immune activation and an increased risk of neurodevelopmental disorders. However, the study of epigenetic changes in these models has been relatively limited, focusing more on behavioral and electrophysiological observations.
Unraveling the Epigenetic Changes
The Salk team's research delved into the epigenetic changes that occur after maternal immune activation. They utilized a viral mimetic Poly(I:C) treatment to mimic influenza exposure and analyzed mouse neurons in the frontal cortex. The study revealed distinct alterations in gene activity and methylation patterns, particularly in deep-layer neurons.
One surprising finding was the increased methylation at sites where the transcription factor Tbr1 binds, a protein essential for defining deep-layer neurons. Despite an abundance of Tbr1, methylation was blocking its ability to regulate gene expression, leading to potential disruptions in neurodevelopment. Interestingly, these Tbr1 sites are also strongly linked to autism spectrum disorders.
Implications and Future Directions
The study's findings have significant implications for our understanding of neurodevelopmental disorders. By demonstrating the lasting impact of prenatal immune challenges, it provides valuable insights into the underlying causes of these conditions. This knowledge can guide the development of maternal or fetal therapeutics aimed at preventing or reducing the risk of neurodevelopmental disorders.
However, many questions remain unanswered. Scientists still need to determine the exact timing of epigenetic changes during brain development and identify the most vulnerable periods for severe illness during pregnancy. Despite these challenges, the research represents a significant step forward in unraveling the complex relationship between maternal illness and neurodevelopmental disorders.
As co-corresponding author Joseph Ecker, PhD, notes, this is just the beginning of the story. The study's findings open up new avenues for research, allowing scientists to explore the consequences of maternal infection with a more detailed understanding of epigenetic modifications. As co-corresponding author Margarita Behrens, PhD, adds, it's the tip of the iceberg, and the field is poised for exciting advancements in the coming years.
